Multiple significant molecules were found in both MCI and AD compared to ND. Moreover, some significant associations between the altered metabolites and the CSF biomarkers in AD were observed. Further studies in larger cohort of samples will be necessary to validate the promising hypothesis and results presented here to determine which of these small molecules may reveal insights into disease progression.